2026Q1
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| Ra Capital Management, L.P. | — | 3,290,000 | Oct 2, 2020 |
| Kolchinsky Peter | — | 3,290,000 | Oct 2, 2020 |
| Shah Rajeev M. | — | 3,290,000 | Oct 2, 2020 |
| Mignone Roberto | 10% Owner | 2,968,115 | Nov 15, 2016 |
| Bridger Management, Llc | Other | 2,968,115 | Nov 15, 2016 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 13, 2026 | Feb 18, 2026 | Lindsay Brigitte Ute | Chief Accounting Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 17, 2026 | Feb 18, 2026 | Mohindru Mani | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 9, 2026 | Lindsay Brigitte Ute | Chief Accounting Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jul 30, 2025 | Jul 31, 2025 | PACE GARY W | Director | Buy | 97.5 | +290,000 | 12.15% | ✗ | $710.5K |
| Jul 8, 2025 | Sidhu Roger | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jun 26, 2025 | Jun 30, 2025 | TANNENBAUM RENEE P | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 26, 2025 | Jun 30, 2025 | Markin Rodney S | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 26, 2025 | Jun 30, 2025 | Mohindru Mani | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 26, 2025 | Jun 27, 2025 | Armitage James O | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 26, 2025 | Jun 27, 2025 | White Lale | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 26, 2025 | Jun 27, 2025 | PACE GARY W | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 11, 2025 | Mar 13, 2025 | Kabbinavar Fairooz | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 11, 2025 | Mar 13, 2025 | Levine James E. | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 11, 2025 | Mar 13, 2025 | Smeal Tod | Chief Scientific Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 11, 2025 | Mar 13, 2025 | Erlander Mark | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 16, 2024 | Dec 18, 2024 | Levine James E. | CFO | Buy | 91.3 | +7,716 | 12.86% | ✗ | $36.7K |
| Dec 12, 2024 | Dec 16, 2024 | TANNENBAUM RENEE P | Director | Buy | 91.3 | +10,000 | 100.00% | ✗ | $34.2K |
| Dec 11, 2024 | Dec 12, 2024 | PACE GARY W | Director | Buy | 97.5 | +361,615 | 20.72% | ✗ | $940.2K |
| Jun 27, 2024 | Jul 1, 2024 | White Lale | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 27, 2024 | Jul 1, 2024 | TANNENBAUM RENEE P | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 27, 2024 | Jul 1, 2024 | Mohindru Mani | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 27, 2024 | Jul 1, 2024 | PACE GARY W | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 27, 2024 | Jul 1, 2024 | Armitage James O | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 27, 2024 | Jul 1, 2024 | Markin Rodney S | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 7, 2024 | Mar 7, 2024 | Levine James E. | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 7, 2024 | Mar 7, 2024 | Kabbinavar Fairooz | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 7, 2024 | Mar 7, 2024 | Smeal Tod | Chief Scientific Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 7, 2024 | Mar 7, 2024 | Erlander Mark | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 19, 2023 | Dec 19, 2023 | PACE GARY W | Director | Buy | 83.8 | +30,000 | 4.49% | ✗ | $41.1K |
| Nov 10, 2023 | Nov 14, 2023 | PACE GARY W | Director | Buy | 83.8 | +22,950 | 3.56% | ✗ | $22.5K |
| Jun 15, 2023 | Jun 20, 2023 | Markin Rodney S | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 15, 2023 | Jun 20, 2023 | Armitage James O | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 15, 2023 | Jun 20, 2023 | White Lale | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 15, 2023 | Jun 20, 2023 | PACE GARY W | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 15, 2023 | Jun 20, 2023 | Mohindru Mani | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 15, 2023 | Jun 20, 2023 | TANNENBAUM RENEE P | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 15, 2023 | Mar 16, 2023 | Smeal Tod | Chief Scientific Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 15, 2023 | Mar 16, 2023 | Levine James E. | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 15, 2023 | Mar 16, 2023 | Kelemen Vicki | COO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 15, 2023 | Mar 16, 2023 | Erlander Mark | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 9, 2023 | Kabbinavar Fairooz | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Nov 25, 2022 | Nov 29, 2022 | Erlander Mark | CEO | Buy | 91.3 | +10,000 | 69.06% | ✗ | $14.3K |
| Sep 16, 2022 | Oct 11, 2022 | Armitage James O | Director | Buy | 91.3 | +13,000 | 100.00% | ✗ | $20.2K |
| Sep 19, 2022 | Sep 20, 2022 | White Lale | Director | Buy | 91.3 | +15,000 | 15.18% | ✗ | $24.5K |
| Sep 15, 2022 | Sep 19, 2022 | TANNENBAUM RENEE P | Director | Buy | 91.3 | +10,000 | 100.00% | ✗ | $17.2K |
| Sep 15, 2022 | Sep 19, 2022 | PACE GARY W | Director | Buy | 97.5 | +150,000 | 30.31% | ✗ | $256.5K |
| Sep 16, 2022 | Sep 19, 2022 | Levine James E. | CFO | Buy | 91.3 | +30,000 | 100.00% | ✗ | $46.7K |
| Jul 5, 2022 | Jul 6, 2022 | White Lale | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 9, 2022 | Jun 9, 2022 | BRANCACCIO JOHN P | Other | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 9, 2022 | Mar 11, 2022 | PACE GARY W | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 9, 2022 | Mar 10, 2022 | White Lale | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 9, 2022 | Mar 10, 2022 | TANNENBAUM RENEE P | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 9, 2022 | Mar 10, 2022 | Ruffner Katherine L | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 9, 2022 | Mar 10, 2022 | Mohindru Mani | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 9, 2022 | Mar 10, 2022 | Markin Rodney S | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 9, 2022 | Mar 10, 2022 | Levine James E. | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 9, 2022 | Mar 10, 2022 | Kelemen Vicki | COO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 9, 2022 | Mar 10, 2022 | Erlander Mark | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 9, 2022 | Mar 10, 2022 | BRANCACCIO JOHN P | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 9, 2022 | Mar 10, 2022 | Armitage James O | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 14, 2022 | Smeal Tod | Chief Scientific Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Sep 21, 2021 | Sep 22, 2021 | PACE GARY W | Director | Buy | 90.0 | +30,000 | 6.45% | ✗ | $202.5K |
| Sep 10, 2021 | Sep 13, 2021 | Levine James E. | CFO | Buy | 95.0 | +30,000 | 100.00% | ✗ | $194K |
| Jul 12, 2021 | Jul 14, 2021 | Ruffner Katherine L | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 13, 2021 | Ruffner Katherine L | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jul 12, 2021 | Jul 12, 2021 | Levine James E. | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 12, 2021 | Levine James E. | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jun 10, 2021 | Jun 15, 2021 | JACOB GARY S | Other | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 10, 2021 | Jun 14, 2021 | White Lale | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 10, 2021 | Jun 14, 2021 | TANNENBAUM RENEE P | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 10, 2021 | Jun 14, 2021 | PACE GARY W | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 10, 2021 | Jun 14, 2021 | Mohindru Mani | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 10, 2021 | Jun 14, 2021 | Markin Rodney S | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 10, 2021 | Jun 14, 2021 | Kelemen Vicki | COO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 10, 2021 | Jun 14, 2021 | Erlander Mark | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 10, 2021 | Jun 14, 2021 | BRANCACCIO JOHN P | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 10, 2021 | Jun 14, 2021 | Armitage James O | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 10, 2021 | Jun 14, 2021 | ADAMS THOMAS PHD | Other | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 14, 2021 | TANNENBAUM RENEE P | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jun 14, 2021 | Mohindru Mani | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Mar 19, 2021 | May 27, 2021 | Armitage James O | Director | Buy | 91.3 | +4,000 | 38.13% | ✗ | $43.3K |
| Mar 26, 2021 | Mar 29, 2021 | Markin Rodney S | Director | Buy | 91.3 | +2,900 | 10.30% | ✗ | $29.9K |
| Mar 23, 2021 | Mar 24, 2021 | PACE GARY W | Director | Buy | 82.5 | +10,000 | 2.20% | ✗ | $102.3K |
| Mar 23, 2021 | Mar 23, 2021 | JACOB GARY S | Director | Buy | 91.3 | +2,370 | 12.12% | ✗ | $24.7K |
| Mar 23, 2021 | Mar 23, 2021 | Kelemen Vicki | COO | Buy | 90.0 | +960 | 18.85% | ✗ | $9.9K |
| Mar 23, 2021 | Mar 23, 2021 | Erlander Mark | CEO | Buy | 85.0 | +965 | 7.14% | ✗ | $10K |
| Mar 22, 2021 | Mar 22, 2021 | BRANCACCIO JOHN P | Director | Buy | 91.3 | +3,000 | 32.40% | ✗ | $32.9K |
| Mar 18, 2021 | Mar 19, 2021 | PACE GARY W | Director | Buy | 68.8 | +3,000 | 0.66% | ✗ | $31.7K |
| Mar 4, 2021 | Mar 4, 2021 | PACE GARY W | Director | Buy | 61.3 | +1,500 | 0.33% | ✗ | $13.9K |
| Jan 2, 2021 | Jan 5, 2021 | Kelemen Vicki | COO | Neutral | 50.0 | -31 | -0.60% | ✗ | - |
| Jan 2, 2021 | Jan 5, 2021 | Erlander Mark | CEO | Neutral | 50.0 | -113 | -0.83% | ✗ | - |
| Nov 23, 2020 | Nov 25, 2020 | Kelemen Vicki | COO | Sell | 20.0 | -35,321 | -87.48% | ✗ | $657K |
| Oct 2, 2020 | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Sep 16, 2020 | Sep 17, 2020 | PACE GARY W | Director | Buy | 68.8 | +2,550 | 0.57% | ✗ | $14.5K |
| Jun 22, 2020 | Kelemen Vicki | COO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jun 17, 2020 | Jun 19, 2020 | PACE GARY W | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 17, 2020 | Jun 19, 2020 | Armitage James O | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 17, 2020 | Jun 19, 2020 | White Lale | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 17, 2020 | Jun 19, 2020 | BRANCACCIO JOHN P | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 17, 2020 | Jun 19, 2020 | JACOB GARY S | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |